Journal of General Internal Medicine

, Volume 16, Issue 12, pp 831–837 | Cite as

Prostate cancer screening practices and beliefs

A longitudinal physician survey
  • John D. Voss
  • Joel M. Schectman
Original Articles


OBJECTIVE: To examine primary care physician prostate-specific antigen (PSA) testing and prostate cancer screening beliefs, practices, and trends over time.

DESIGN: Longitudinal physician survey.

SETTING: Community and academic primary care practices in a major East Coast city.

PARTICIPANTS: Physicians with ≥100 patients enrolled in an HMO serving 90,000 patients were surveyed in 1993 and 1998 regarding prostate cancer screening beliefs and practices. In 1993, 176 physicians (76%) completed the survey. In 1998, 76% of the 1993 respondents responded to a second survey. Associations between and changes over time in beliefs and self-reported PSA testing were analyzed.

MEASUREMENTS AND MAIN RESULTS: Physicians reported ordering PSA tests in 73% of health maintenance exams (HMEs) in 1993 and 81% of HMEs in 1998. PSA testing significantly increased between 1993 and 1998 with 43% of physicians reporting increased testing and only 13% reporting reduced testing. Between 1993 and 1998, physician attitudes favoring PSA testing increased although less than half of physicians believed that aggressive early treatment improved patient outcomes. Community versus academic practice location was also associated with PSA testing.

CONCLUSIONS: Physicians reported high and increasing rates of PSA testing from 1993 to 1998 and more favorable attitudes toward PSA testing. Despite conflicting expert recommendations and a lack of consistent, high-quality supporting evidence, PSA screening appears to be increasingly considered a standard of care by practicing physicians. However, beliefs other than improved patient outcomes due to screening may be the primary drivers of increased PSA testing.

Key words

prostate cancer screening prostate-specific antigen 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. Ca Cancer J Clin. 2001;51:15–25.PubMedCrossRefGoogle Scholar
  2. 2.
    Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst. 1999;91:1017–24.PubMedCrossRefGoogle Scholar
  3. 3.
    Boyle P. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy. Ann Oncol. 1998;9:1263–4.PubMedCrossRefGoogle Scholar
  4. 4.
    American College of Physicians. Screening for prostate cancer. Ann Intern Med. 1997;126:480–4.Google Scholar
  5. 5.
    U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd Ed. Screening for Prostate Cancer. Baltimore, Md: Williams and Wilkins; 1996:119–34.Google Scholar
  6. 6.
    Ferrini R, Woolf SH. Screening for prostate cancer in American men. Am J Prev Med. 1998;15:81–4.PubMedCrossRefGoogle Scholar
  7. 7.
    American Academy of Family Physicians. AAFP Reference Manual, 1997–1998, Appendix F-Periodic Health Examination. Kansas City, Mo: American Academy of Physicians; 1998:62.Google Scholar
  8. 8.
    Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. Ca Cancer J Clin. 1993;43:42–6.PubMedGoogle Scholar
  9. 9.
    American Urologic Association. Executive Committee Report. Baltimore, Md: American Urologic Association; January 1992.Google Scholar
  10. 10.
    Von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins M. American Cancer Society guidelines for the early detection of prostate cancer: update 1997. Ca Cancer J Clin. 1997;47:261–4.Google Scholar
  11. 11.
    Smith RA, von Eschenback AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Ca Cancer J Clin. 2001;51:38–51.PubMedGoogle Scholar
  12. 12.
    Fowler FJ, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:526–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Hoffman RM, Buller DB, Papenfuss MR, Moon TE. Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prev Med. 1996;12:277–81.PubMedGoogle Scholar
  14. 14.
    McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC. Screening for prostate cancer: a comparison of urologists and primary care physicians. Singapore Med J. 1996;89:885–8.Google Scholar
  15. 15.
    Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice. Arch Fam Med. 1995;4:311–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Hicks RJ, Hamm RM, Bemben DA. Prostate cancer screening. Arch Fam Med. 1995;4:317–22.PubMedCrossRefGoogle Scholar
  17. 17.
    Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. Arch Fam Med. 1997;6:453–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Edlefsen KA, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N. Prostate-specific antigen for prostate cancer screening. Am J Prev Med. 1999;17:87–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women. Does the sex of the physician matter? New Engl J Med. 1993;329:478–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Franks P, Clancy CM. Physician gender bias in clinical decision-making: screening for cancer in primary care. Med Care. 1993;31:213–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Sackett DL, Holland WW. Controversy in the detection of disease. Lancet. 1975;2:357–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Collins MM, Barry MJ. Controversies in prostate cancer screening: analogies to the early lung cancer screening debate. JAMA. 1996;276:1976–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Mauser JS, Kramer S. Epidemiology. Philadelphia: W.B. Saunders Company; 1985:228–30.Google Scholar
  24. 24.
    Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown and Company; 1985;139–55.Google Scholar
  25. 25.
    Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156:1333–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11:342–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8:333–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Frosch DL, Kaplan RM, Felitti V. Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001;16:391–8.PubMedCrossRefGoogle Scholar

Copyright information

© Blackwell Science Inc 2001

Authors and Affiliations

  • John D. Voss
    • 1
  • Joel M. Schectman
    • 1
  1. 1.the Division of General Medicine, Department of Internal MedicineUniversity of Virginia Health SystemCharlottesville

Personalised recommendations